| Schedule of corrections and consolidated financial statements |
| | | As of and for the Period Ended
June 30, 2016 | | | ITEMS | | Previously
Reported | | | Adjustments | | | Restated | | | | | | | | | | | | | | Consolidated Statements of Balance Sheets | | | | | | | | | | | Prepayment | | | 3,500,000 | | | | (3,500,000 | ) | | | - | | | Due to related party | | | - | | | | 6,500,000 | | | | 6,500,000 | | | Accumulated deficit | | | (669,207 | ) | | | (10,000,000 | ) | | | (10,669,207 | ) | | | | | | | | | | | | | | | | Consolidated Statements of Operations and Comprehensive Loss | | | | | | | | | | | | | | For the nine months ended June 30, 2016 | | | | | | | | | | | | | | Research and development expenses | | | - | | | | 10,000,000 | | | | 10,000,000 | | | Net Loss | | | (352,796 | ) | | | (10,000,000 | ) | | | (10,352,796 | ) | | Basic and diluted loss per share | | | (0.00 | ) | | | (0.05 | ) | | | (0.05 | ) | | | | | | | | | | | | | | | | Consolidated Statements of Cash Flow | | | | | | | | | | | | | | Net loss from operating activities | | | (353,605 | ) | | | (10,000,000 | ) | | | (10,353,605 | ) | | Issuance of common stock for compensation | | | - | | | | 897,521 | | | | 897,521 | | | (Increase) decreases in prepayment | | | (3,496,185 | ) | | | 3,500,000 | | | | 3,815 | | | (Increase) decrease in due from related party | | | 350,000 | | | | (350,000 | ) | | | - | | | Increase (decrease) in due to related party | | | (22,517 | ) | | | 6,500,000 | | | | 6,477,483 | | | Increase (decrease) in due to shareholder | | | (46,586 | ) | | | 46,586 | | | | - | | | Net cash used in operating activities | | | (3,857,447 | ) | | | 594,107 | | | | (3,263,340 | ) | | | | | | | | | | | | | | | | (Increase) decrease in due to shareholder | | | - | | | | (46,586 | ) | | | (46,586 | ) | | Proceeds from subscription receivable | | | - | | | | 350,000 | | | | 350,000 | | | Proceeds from issuance of common stock | | | 897,521 | | | | (897,521 | ) | | | - | | | Net cash used in financing activities | | | 2,947,521 | | | | (594,107 | ) | | | (2,353,414 | ) |
|
| Schedule of adjustments on previously reported consolidated financial statements |
| | | Previously
Reported on Form 10K | | | Adjustments No.1 | | | Adjustments No.2 | | | Restated | | | | | | | | | | | | | | | | | Consolidated Balance Sheet | | | | | | | | | | | | | | As of September 30, 2016 | | | | | | | | | | | | | | | | | | Due to related party | | | - | | | | 6,500,000 | | | | - | | | | 6,500,000 | | | Total Liabilities | | | 56,470 | | | | 6,500,000 | | | | - | | | | 6,556,470 | | | Additional paid-in capital | | | 4,733,401 | | | | - | | | | 60 | | | | 4,733,461 | | | Accumulated deficit | | | (4,823,401 | ) | | | (6,500,000 | ) | | | - | | | | (11,323,401 | ) | | Total equity (deficit) | | | 120,882 | | | | (6,500,000 | ) | | | - | | | | (6,379,118 | ) | | | | | | | | | | | | | | | | | | | | Consolidated Statements of Operations and Comprehensive Loss | | | | | | | | | | | | | | | | | | For the year ended September 30, 2016 | | | | | | | | | | | | | | | | | | Selling, general and administrative expenses | | | 4,497,263 | | | | (3,500,060 | ) | | | 60 | | | | 997,263 | | | Research and development expenses | | | - | | | | 10,000,000 | | | | - | | | | 10,000,000 | | | Net loss from operations | | | (4,497,295 | ) | | | (6,499,940 | ) | | | (60 | ) | | | (10,997,295 | ) | | Loss from continuing operations before income taxes | | | (4,506,963 | ) | | | (6,499,940 | ) | | | (60 | ) | | | (11,006,963 | ) | | Net Loss | | | (4,507,799 | ) | | | (6,499,940 | ) | | | (60 | ) | | | (11,007,799 | ) | | Basic and diluted loss per share | | | (0.00 | ) | | | (0.06 | ) | | | (0.00 | ) | | | (0.06 | ) | | Consolidated Statements of Cash Flow | | | | | | | | | | | | | | | | | For the year ended September 30, 2016 | | | | | | | | | | | | | | | | | | Net loss from continuing operations | | | (4,507,799 | ) | | | (6,499,940 | ) | | | (60 | ) | | | (11,007,799 | ) | | Issuance of common stock for compensation | | | 1,295,324 | | | | (60 | ) | | | 60 | | | | 1,295,324 | | | (Decrease) increase in due to related party | | | (22,517 | ) | | | 6,500,000 | | | | | | | | 6,477,483 | | | | | | | | | | | | | | | | | | | | Consolidated Statements of Cash Flow | | | | | | | | | | | | | | | | | | For the year ended September 30, 2015 | | | | | | | | | | | | | | | | | | Net cash used in operating activities | | | (517) | | | | - | | | | (198 | ) | | | (715 | ) |
|